Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Sarepta Therapeutics (NASDAQ: SRPT)

$34.86 USD -$0.95 (-2.65%)
Last Price $34.86
Net Change $-0.95 (-2.65%)
Bid $30.41
Ask Price $34.8
Open Price $35.98
Previous Close Price $35.81
High Price $36.06
Low Price $33.93
Number of Trades 14,007
Volume 2,836,597
Fifty Two Week High $63.73 (2016-09-28)
Fifty Two Week Low $10.45 (2016-04-27)
Average Daily Volume 2,410,252
Share Outstanding 54,810 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.71 (2017-02-28)
2nd Quarter Earnings $-0.95 (2016-10-27)
3nd Quarter Earnings $-1.19 (2016-07-19)
4th Quarter Earnings $-1.15 (2016-05-05)
PE Ratio $0
EPS Growth $45.05
Recent Earnings $-0.71
Annual EPS $-5.33
Last Quarter EPS $
Market Capitalization $1.91B
Insider Shareholders % 0.109%
Annual Revenue $0B
No. Shares Outstanding 54,810
Inst. Shareholder % 71.99%
Annual Net Income $0B
TTM Net Profit Margin $102.13
1-Year Return 224.95%
3-Year Return -1.51%
5-Year Return 619.08%
5-Year Revenue Growth -88.47%
5-Year Earnings Growth 4400%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 45.049999%
Dividends per Share $
Stock Split Ratio 1-6
Beta 1.66
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.